Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2021 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Ben Matone - Senior Director, IR Dr. Joseph Kim - President and CEO Peter Kies - CFO Dr. Jeffrey Skolnik - SVP, Clinical Development Dr. Kate Broderick - SVP, Research and Development Conference Call Participants Hartaj Singh - Oppenheimer Stephen Willey - Stifel Roger Song - Jefferies Yi Chen - H.C. Wainwright Operator Good afternoon and welcome to the Inovio Pharmaceuticals Fourth Quarte ...